Publications by authors named "Peter Foley"

Claim this Profile
W
Waiting for Access: How Bureaucracy Blocks Innovation in Australian Dermatology.
Conor Larney, Peter Foley, Benjamin S Daniel

Australas J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shedding Light on Actinic Prurigo: A Systematic Review of Emerging Therapies.
Conor Larney, Philip Lee, Zachary Holmes, Benjamin S Daniel, Chris Baker, Peter Foley

Australas J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the Future Oral? Towards Sustainable and Patient-Centered Biologic Treatment in Dermatology.
Conor Larney, Peter Foley, Benjamin S Daniel

Australas J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasis.
Mark Lebwohl, Melinda J Gooderham, Richard B Warren, Diamant Thaçi, Peter Foley

Clin Exp Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Side-Effects of Dupilumab: A Narrative Review.
Conor Larney, Peter Foley, Jason Wu, Benjamin S Daniel

Australas J Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus on the Use of JAKinibs for Atopic Dermatitis in Australia and New Zealand. An eDelphi by the Australasian Medical Dermatology Group.
Marius Rademaker, Peter Foley, Katherine Armour, Christopher Baker, Kurt Gebauer

Australas J Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study.
Stephan Weidinger, Andrew Blauvelt, Kim A Papp, Adam Reich, Chih-Hung Lee, Peter Foley

Immunotherapy· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of Live Attenuated Vaccine Administration in Patients Undergoing Treatment With Dupilumab and Apremilast: A Systematic Review.
Conor Larney, Peter Foley, Benjamin S Daniel

Australas J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wolf's Isotopic Response: A Rare Case of Terra Firma-Forme Dermatosis on Resolved Psoriatic Plaques.
Conor Larney, Peter A Foley, Senhong Lee

Australas J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eight-Year Experience of Hedgehog Pathway Inhibitors at Three Tertiary Referral Centres in the Australian State of Victoria.
Christian Gan, Nicholas Manuelpillai, Peter Foley, Christopher McCormack, Michelle S Goh

Australas J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib for Chronic Actinic Dermatitis: A Case Report and Literature Review of JAK Inhibitor Use for Recalcitrant Disease.
Zachary Holmes, Conor Larney, Peter Foley, Chris Baker, Benjamin S Daniel

Australas J Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Survival of Biological Therapies in Smokers and Non-Smokers With Psoriasis: A Retrospective Cohort Study Using Data From the Australasian Psoriasis Registry.
Ferial May, Julie Armstrong, Sara Vogrin, Christopher Baker, Peter Foley

Australas J Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.
Stephan Weidinger, Andrew Blauvelt, Kim A Papp, Adam Reich, Chih-Hung Lee, Peter Foley

J Allergy Clin Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Australasian hidradenitis suppurativa management guidelines.
John Frew, Annika Smith, Pablo Fernandez Penas, Elisabeth Ellis, Peter Foley

Australas J Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case Series.
Conor Larney, Peter Foley, Kurt Gebauer, Benjamin S Daniel

Australas J Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Delphi consensus on treatment goals for generalized pustular psoriasis.
Jonathan N Barker, Emmylou Casanova, Siew Eng Choon, Peter Foley, Hideki Fujita

Br J Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy.
Jonathan I Silverberg, Thomas Bieber, Amy S Paller, Lisa Beck, Masahiro Kamata, Peter Foley

Dermatol Ther (Heidelb)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc Analyses.
Kenneth B Gordon, Joseph F Merola, Peter Foley, Olivia Choi, Daphne Chan

J Drugs Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A global perspective on the treatment and maintenance of mature skin using gentle cleansers and moisturizers.
Joachim W Fluhr, Andrew F Alexis, Anneke Andriessen, Olga L Ferero Barrios, Peter Bjerring, Peter Foley

Int J Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asia-Pacific consensus recommendations on the management of generalized pustular psoriasis.
Siew Eng Choon, Peter Anthony Foley, Pravit Asawanonda, Hideki Fujita, Seong-Jin Jo

J Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pityriasis rosea-like drug eruption secondary to deucravacitinib.
Nisal Punchihewa, Senhong Lee, Chin-Guan Tan, Peter Foley

JAAD Case Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis.
April W Armstrong, Peter Foley, Yan Liu, Megan Miller, Rachel E Teneralli

Dermatol Ther (Heidelb)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions.
Fiona James, Michelle S Goh, Sara Vogrin, Irvin Ng, Abby P Douglas, Peter Foley

World Allergy Organ J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegeneration.
Rozanna Meijboom, Peter Foley, Niall J J MacDougall, Yair Mina, Elizabeth N York

Brain Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis